G360 2025: The newest in MIGS and what it means for comanagement

News
Video

Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.

Shan Lin, MD, is the co-research director at the Glaucoma Center of San Francisco. At the Glaucoma 360 meeting, he discussed the new generation of minimally invasive glaucoma surgeries (MIGS). These include trabecular procedures like the CyPass which removes part of the trabecular meshwork, suprachoroidal stents like the iStent, and scleral-based procedures like Xen. There are also new minimally invasive filtration surgeries like the Preserflo MicroShunt. Lin notes that the introduction of prostaglandin eye drops and SLT laser have greatly improved glaucoma management. The new MIGS procedures allow for further delaying the need for more invasive filtering surgeries. Lin believes the field of glaucoma will continue to see evolutionary development of new MIGS.

Another area of potential progress is in neuroprotection. While an earlier trial of memantine did not pan out, Lin is optimistic that new neuroprotective agents are on the horizon as research into the underlying mechanisms of glaucoma advances. Beyond medications and surgery, Lin discusses other potential therapies. Exercise, a healthy diet, and certain supplements like nicotinamide and citicoline show promise in clinical studies.

Lin emphasizes the importance of collaboration between ophthalmologists and optometrists as the population of glaucoma patients grows. Optometrists are often the first point of contact and can help get patients to the right specialist for treatment.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
ODs reflect on their time in Minneapolis, Minnesota, citing continuing education, tech updates, and networking opportunities as valued takeaways from the meeting.
Nora Lee Cothran, OD, FAAO, discussed the importance of optometrists addressing mental health with patients in their chair.
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Shawn Hobbs, OD, previews the annual NOA convention, which takes place in Columbus, Ohio, from July 10 to 12, 2025.
Clark Chang, OD, MSA, MSc, FAAO, gave a presentation alongside Susan Gromacki, OD, MS, FAAO, FSLS, at this year's Optometry's Meeting.
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
© 2025 MJH Life Sciences

All rights reserved.